Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection

World Journal of Surgery

Volumn 35, Issue 4, 2011, Pages 798-804

  Kosuga, Toshiyuki ^a   Shiozaki, Atsushi ^a   Fujiwara, Hitoshi ^a   Ichikawa, Daisuke ^a   Okamoto, Kazuma ^a   Komatsu, Shuhei ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COHORT ANALYSIS; DISEASE FREE SURVIVAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; JAPAN; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; SURVIVAL; THORAX; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THORAX; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952195443     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-0978-x     Document Type: Article

References (26)

1. F Kamangar GM Dores WF Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 2150 16682732 10.1200/JCO.2005.05.2308 (Pubitemid 46655601)
2. JM Daly WA Fry AG Little, et al. 2000 Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study J Am Coll Surg 190 562 573 10801023 10.1016/S1072-7515(00)00238-6 1:STN:280:DC%2BD3c3lvV2lsw%3D%3D (Pubitemid 30230704)
3. N Ando S Ozawa Y Kitagawa, et al. 2000 Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years Ann Surg 232 225 232 10903602 10.1097/00000658-200008000-00013 1:STN:280:DC%2BD3cvgvVGltg%3D%3D (Pubitemid 30616724)
4. S Nakagawa T Kanda S Kosugi, et al. 2004 Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy J Am Coll Surg 198 205 211 14759776 10.1016/j.jamcollsurg.2003.10.005 (Pubitemid 38175235)
5. H Shimada H Kitabayashi Y Nabeya, et al. 2003 Treatment response and prognosis of patients after recurrence of esophageal cancer Surgery 133 24 31 12563234 10.1067/msy.2003.31 (Pubitemid 36183122)
6. C Kunisaki H Makino R Takagawa, et al. 2008 Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy J Gastrointest Surg 12 802 810 17952515 10.1007/s11605-007-0385-7
7. T Nakamura M Ota K Narumiya, et al. 2008 Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection Ann Surg Oncol 15 2451 2457 18592318 10.1245/s10434-008-0016-x
8. Y Ueda A Shiozaki H Itoi, et al. 2006 Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer Oncol Rep 16 1061 1066 17016593
9. Akiyama H (1990) Surgery for cancer of the esophagus. Williams &Wilkins, Baltimore, pp 19-42
10. H Watanabe 1995 The problems of cervico-thoraco abdominal (3-field) lymphadenectomy for thoracic esophageal cancer Ann Thorac Cardiovasc Surg 1 349 353
11. A Shiozaki H Yamagishi H Itoi, et al. 2005 Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer Oncol Rep 13 667 672 15756440 1:CAS:528:DC%2BD2MXjtFansL0%3D
12. Sobin LH, Wittekind CH (eds) (2002) TNM Classification of malignant tumors, vol 6. Wiley-Liss, New York
13. H Kato T Miyazaki M Nakajima, et al. 2004 Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma Br J Surg 91 1004 1009 15286962 10.1002/bjs.4595 1:STN:280:DC%2BD2czot1Cisw%3D%3D (Pubitemid 39070815)
14. JB Roedl MG Harisinghani RR Colen, et al. 2008 Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography Ann Thorac Surg 86 1131 1138 18805147 10.1016/j.athoracsur.2008.05.019
15. H Igaki Y Tachimori H Kato 2004 Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection Ann Surg 239 483 490 15024309 10.1097/01.sla.0000118562.97742.29 (Pubitemid 38372764)
16. M Tachibana S Kinugasa H Yoshimura, et al. 2005 Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma Am J Surg 189 98 109 15701501 10.1016/j.amjsurg.2004.10. 001 (Pubitemid 40215515)
17. S Law J Wong 2001 Two-field dissection is enough for esophageal cancer Dis Esophagus 14 98 103 11553217 10.1046/j.1442-2050.2001.00164.x 1:STN:280:DC%2BD3MrgtlOruw%3D%3D (Pubitemid 32951977)
18. V Gebski B Burmeister BM Smithers, et al. 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 226 234 17329193 10.1016/S1470-2045(07)70039-6 1:CAS:528:DC%2BD2sXisVCqs78%3D (Pubitemid 46291702)
19. H Takeuchi Y Saikawa T Oyama, et al. 2010 Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy World J Surg 34 277 284 20033687 10.1007/s00268-009-0331-9
20. BD Minski TF Pajak RJ Ginsberg, et al. 2002 INT0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy J Clin Oncol 20 1167 1174 10.1200/JCO.20.5.1167 (Pubitemid 34177421)
21. N Ando T Iizuka H Ide, et al. 2003 Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204 J Clin Oncol 21 4592 4596 14673047 10.1200/JCO.2003.12.095 (Pubitemid 46594032)
22. Igaki H, Kato H, Ando N et al (2008) A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). J Clin Oncol 26:15S (May 20 Suppl, Abstr 4510)
23. H Udagawa 2009 Chemoradiotherapy: its effectiveness, toxicity and perspective in the treatment of esophageal cancer Ann Thorac Cardiovasc Surg 15 359 361 20081742
24. S Motoyama M Kitamura R Saito, et al. 2006 Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck World J Surg 30 191 198 16425071 10.1007/s00268-005-0092-z (Pubitemid 43162490)
25. S Nakagawa T Nishimaki S Kosugi, et al. 2003 Cervical lymphadenectomy is beneficial for patients with carcinoma of the upper and mid-thoracic esophagus Dis Esophagus 16 4 8 12581247 10.1046/j.1442-2050.2003.00286.x 1:STN:280:DC%2BD3s%2FntFeguw%3D%3D (Pubitemid 36603487)
26. S Komatsu Y Shioaki D Ichikawa, et al. 2005 Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer Hepatogastroenterology 52 796 799 15966207 (Pubitemid 40834607)